Dong Qu

Statistics

Publications

Citations

586

H-Index

Active since

2017

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Jiangsu Hengrui Medicine (China)

Dong Qu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2017–2022

Publications

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

Jing Huang, Binghe Xu, Hongnan Mo et al. · Clinical Cancer Research · 2018 · 217 citations

Medicine, Oncology, Pharmacology +17

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study

Hongnan Mo, Jing Huang, Jiachen Xu et al. · British Journal of Cancer · 2018 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210

Lanying Ma, Xi Wang, Hongnan Mo et al. · Cancer Biology and Medicine · 2019 · 69 citations · Full text

Medicine, Dermatology, Oncology +17

Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio

Jianfang Liu, Zhu Wang, Huafei Shao et al. · European Radiology · 2017 · 68 citations

Medicine, Oncology, Radiology +17

Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China

Jing Huang, Hongnan Mo, Weilong Zhang et al. · Cancer · 2018 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 6